LIPOCINE INC (LPCN) Top Institutional Shareholders

LIPOCINE INC (LPCN) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $24.91M in LPCN holdings during the latest filing period.

Ikarian Capital, Llc is currently the largest disclosed institutional shareholder of LPCN tracked by InsiderSet, reporting ownership valued at approximately $4.06M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $1.19M, representing an estimated loss of -70.71% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 77% of the total disclosed LPCN value among the investors covered in this analysis. Major shareholders include Ikarian Capital, Llc, Squadron Capital Management Llc, Eversept Partners, Lp, and several other long-term asset managers with concentrated positions in LIPOCINE INC (LPCN).

This page ranks the largest institutional LPCN shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

45

Total Reported Value

$24.91M

Largest Holder

Ikarian Capital, Llc

Largest Position

$4.06M

Insider Transactions (90d)

0

Latest Filing Quarter

Q1 2026

New Institutional Positions

48

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Ikarian Capital, Llc0.58%508,556$4,063,362$1,190,021-$2,873,341-70.71%
Squadron Capital Management Llc1.44%450,000$3,595,500$1,053,000-$2,542,500-70.71%
Eversept Partners, Lp0.16%294,989$2,356,962$690,274-$1,666,688-70.71%
Rosalind Advisors, Inc.0.73%221,616$1,770,712$518,581-$1,252,131-70.71%
Vanguard Capital Management Llc0.00%200,668$1,603,337$469,563-$1,133,774-70.71%
Aigh Capital Management Llc0.33%200,000$1,598,000$468,000-$1,130,000-70.71%
Stempoint Capital Lp0.25%160,420$1,281,756$375,383-$906,373-70.71%
Boothbay Fund Management, Llc0.03%140,487$1,122,491$328,740-$793,751-70.71%
Seven Fleet Capital Management Lp0.32%124,942$998,287$292,364-$705,923-70.71%
Birchview Capital, Lp0.51%111,786$893,170$261,579-$631,591-70.71%
Blackrock, Inc.0.00%89,272$713,283$208,896-$504,387-70.71%
Mink Brook Asset Management Llc0.30%66,812$533,828$156,340-$377,488-70.71%
Geode Capital Management, Llc0.00%63,135$504,741$147,736-$357,005-70.73%
Exome Asset Management Llc0.29%60,861$486,279$142,415-$343,864-70.71%
Diadema Partners Lp0.16%50,000$399,500$117,000-$282,500-70.71%
J. Goldman & Co Lp0.02%42,170$336,938$98,678-$238,260-70.71%
Renaissance Technologies LLCJim Simons0.00%38,497$307,591$90,083-$217,508-70.71%
Two Sigma Investments, Lp0.00%33,750$269,663$78,975-$190,688-70.71%
Vanguard Fiduciary Trust Co0.00%32,413$258,980$75,846-$183,134-70.71%
Citadel Advisors Llc0.00%29,088$232,413$68,066-$164,347-70.71%
Susquehanna International Group, Llp0.00%24,908$199,015$58,285-$140,730-70.71%
Adar1 Capital Management, Llc0.01%23,180$185,208$54,241-$130,967-70.71%
State Street Corp0.00%22,407$179,032$52,432-$126,600-70.71%
Jane Street Group, Llc0.00%20,027$160,016$46,863-$113,153-70.71%
Dimensional Fund Advisors Lp0.00%19,122$152,785$44,745-$108,040-70.71%
Xtx Topco Ltd0.00%17,923$143,205$41,940-$101,265-70.71%
Persistent Asset Partners Ltd0.04%13,442$107,402$31,454-$75,948-70.71%
Northern Trust Corp0.00%13,042$104,206$30,518-$73,688-70.71%
Prelude Capital Management, Llc0.01%12,630$100,914$29,554-$71,360-70.71%
Ameriprise Financial Inc0.00%11,448$91,469$26,788-$64,681-70.71%
Barclays Plc0.00%9,412$75,202$22,024-$53,178-70.71%
Ubs Group Ag0.00%3,494$27,917$8,176-$19,741-70.71%
Wells Fargo & Company/Mn0.00%2,706$21,621$6,332-$15,289-70.71%
Vanguard Global Advisers, Llc0.00%1,691$13,511$3,957-$9,554-70.71%
Tower Research Capital Llc (Trc)0.00%933$7,455$2,183-$5,272-70.71%
Fmr Llc0.00%626$5,005$1,465-$3,540-70.73%
Morgan Stanley0.00%574$4,586$1,343-$3,243-70.71%
Caldwell Sutter Capital, Inc.0.00%471$3,763$1,102-$2,661-70.71%
Osaic Holdings, Inc.0.00%143$1,141$335-$806-70.67%
Group One Trading Llc0.00%132$1,055$309-$746-70.72%
Planvest Financial, Inc0.00%111$887$260-$627-70.72%
Sbi Securities Co., Ltd.0.00%67$535$157-$378-70.70%
Tidemark, Llc0.00%59$471$138-$333-70.69%
Bogart Wealth, Llc0.00%3$24$7-$17-70.75%
Farther Finance Advisors, Llc0.00%1$9$2-$7-74.00%

Frequently asked questions about LPCN

  • Who owns the most LPCN stock?

    The largest holders of LPCN are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for LIPOCINE INC (LPCN).

  • Is LPCN widely held by superinvestors?

    Many widely followed stocks like LPCN appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly LPCN is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.